NEDD9 and BCAR1 negatively regulate E-cadherin membrane localization, and promote E-cadherin degradation

PLoS ONE

Volumn 6, Issue 7, 2011, Pages

  Tikhmyanova, Nadezhda ^a,b   Golemis, Erica A ^a  

^a FOX CHASE CANCER CENTER   (United States)

^b DREXEL UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CRK ASSOCIATED SUBSTRATE PROTEIN; PROTEIN NEDD9; PROTEIN TYROSINE KINASE; SCAFFOLD PROTEIN; UNCLASSIFIED DRUG; UVOMORULIN; BCAR1 PROTEIN, HUMAN; CADHERIN; CAS L PROTEIN, MOUSE; CAS-L PROTEIN, MOUSE; CDH1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; DETERGENT; FZR1 PROTEIN, MOUSE; NEDD9 PROTEIN, HUMAN; PHOSPHOPROTEIN; PROTEIN KINASE INHIBITOR; SIGNAL TRANSDUCING ADAPTOR PROTEIN;

ANIMAL TISSUE; ARTICLE; CELL ADHESION; CELLULAR DISTRIBUTION; CONTROLLED STUDY; HUMAN; HUMAN CELL; NONHUMAN; PROTEIN DEGRADATION; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; ANIMAL; CELL FRACTIONATION; CELL JUNCTION; CELL MEMBRANE; DOWN REGULATION; DRUG ANTAGONISM; DRUG EFFECT; ENZYME ACTIVATION; LYSOSOME; METABOLISM; MOUSE; MOUSE MAMMARY TUMOR ONCOVIRUS; PROTEIN PROCESSING; PROTEIN TRANSPORT; SOLUBILITY; TUMOR CELL LINE;

MAMMALIA; MOUSE MAMMARY TUMOR VIRUS; MUS; POLYOMAVIRUS;

ADAPTOR PROTEINS, SIGNAL TRANSDUCING; ANIMALS; CADHERINS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CELL MEMBRANE; CRK-ASSOCIATED SUBSTRATE PROTEIN; DETERGENTS; DOWN-REGULATION; ENZYME ACTIVATION; HUMANS; INTERCELLULAR JUNCTIONS; LYSOSOMES; MAMMARY TUMOR VIRUS, MOUSE; MICE; PHOSPHOPROTEINS; PROTEIN KINASE INHIBITORS; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTEIN TRANSPORT; SOLUBILITY; SRC-FAMILY KINASES; SUBCELLULAR FRACTIONS;

EID: 79960182540     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0022102     Document Type: Article

References (45)

1. Defilippi P, Di Stefano P, Cabodi S, (2006) p130Cas: a versatile scaffold in signaling networks. Trends Cell Biol 16: 257-263.
2. Singh M, Cowell L, Seo S, O'Neill G, Golemis E, (2007) Molecular basis for HEF1/NEDD9/Cas-L action as a multifunctional co-ordinator of invasion, apoptosis and cell cycle. Cell Biochem Biophys 48: 54-72.
3. Tikhmyanova N, Little JL, Golemis EA, (2010) CAS proteins in normal and pathological cell growth control. Cell Mol Life Sci 67: 1025-1048.
4. Sakai R, Iwamatsu A, Hirano N, Ogawa S, Tanaka T, et al. (1994) A novel signaling molecule, p130, forms stable complexes in vivo with v-Crk and v-Src in a tyrosine phosphorylation-dependent manner. EMBO J 13: 3748-3756.
5. Law SF, Estojak J, Wang B, Mysliwiec T, Kruh GD, et al. (1996) Human Enhancer of Filamentation 1 (HEF1), a novel p130Cas-like docking protein, associates with FAK, and induces pseudohyphal growth in yeast. Mol Cell Biol 16: 3327-3337.
6. Ishino M, Ohba T, Sasaki H, Sasaki T, (1995) Molecular cloning of a cDNA encoding a phosphoprotein, Efs, which contains a Src homology 3 domain and associates with Fyn. Oncogene 11: 2331-2338.
7. Singh MK, Dadke D, Nicolas E, Serebriiskii IG, Apostolou S, et al. (2008) A Novel Cas Family Member, HEPL, Regulates FAK and Cell Spreading. Mol Biol Cell 19: 1627-1636.
8. O'Neill GM, Seo S, Serebriiskii IG, Lessin SR, Golemis EA, (2007) A new central scaffold for metastasis: parsing HEF1/Cas-L/NEDD9. Cancer Res 67: 8975-8979.
9. Brabek J, Constancio SS, Siesser PF, Shin NY, Pozzi A, et al. (2005) Crk-associated substrate tyrosine phosphorylation sites are critical for invasion and metastasis of SRC-transformed cells. Mol Cancer Res 3: 307-315.
10. Cabodi S, Tinnirello A, Di Stefano P, Bisaro B, Ambrosino E, et al. (2006) p130Cas as a new regulator of mammary epithelial cell proliferation, survival, and HER2-neu oncogene-dependent breast tumorigenesis. Cancer Res 66: 4672-4680.
11. Brinkman A, van der Flier S, Kok EM, Dorssers LC, (2000) BCAR1, a human homologue of the adapter protein p130Cas, and antiestrogen resistance in breast cancer cells. J Natl Cancer Inst 92: 112-120.
12. van der Flier S, Brinkman A, Look MP, Kok EM, Meijer-Van Gelder ME, et al. (2000) Bcar1/p130Cas protein and primary breast cancer: prognosis and response to tamoxifen treatment. J Natl Cancer Inst 92: 120-127.
13. Natarajan M, Stewart JE, Golemis EA, Pugacheva EN, Alexandropoulos K, et al. (2006) HEF1 is a necessary and specific downstream effector of FAK that promotes the migration of glioblastoma cells. Oncogene 25: 1721-1732.
14. Kim M, Gans JD, Nogueira C, Wang A, Paik JH, et al. (2006) Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell 125: 1269-1281.
15. Ji H, Ramsey MR, Hayes DN, Fan C, McNamara K, et al. (2007) LKB1 modulates lung cancer differentiation and metastasis. Nature 448: 807-810.
16. Minegishi M, Tachibana K, Sato T, Iwata S, Nojima Y, et al. (1996) Structure and function of Cas-L, a 105-kD Crk-associated substrate-related protein that is involved in beta-1 integrin-mediated signaling in lymphocytes. J Exp Med 184: 1365-1375.
17. Astier A, Manie SN, Law SF, Canty T, Hagheyeghi N, et al. (1997) Association of the Cas-like molecule HEF1 with CrkL following integrin and antigen receptor signaling in B cells. Possible relevance to neoplastic lymphohematopoietic cells. Leuk Lymph 28: 65-72.
18. Manie SN, Beck ARP, Astier A, Law SF, Canty T, et al. (1997) Involvement of p130Cas and p105HEF1, a novel Cas-like docking protein, in a cytoskeleton-dependent signaling pathway initiated by ligation of integrin or antigen receptor on human B cells. J Biol Chem 272: 4230-4236.
19. Sattler M, Salgia R, Shrikhande G, Verma S, Uemura N, et al. (1997) Differential signaling after beta1 integrin ligation is mediated through binding of CRKL to p120CBL and p110HEF1. J Biol Chem 272: 14320-14326.
20. van Seventer GA, Salman HJ, Law SF, O'Neill GM, Mullen MM, et al. (2001) Focal adhesion kinase regulates beta1 integrin dependent migration through an HEF1 effector pathway. Eur J Imm 31: 1417-1427.
21. Fashena SJ, Einarson MB, O'Neill GM, Patriotis CP, Golemis EA, (2002) Dissection of HEF1-dependent functions in motility and transcriptional regulation. J Cell Sci 115: 99-111.
22. Izumchenko E, Singh MK, Plotnikova OV, Tikhmyanova N, Little JL, et al. (2009) NEDD9 promotes oncogenic signaling in mammary tumor development. Cancer Res 69: 7198-7206.
23. Singh MK, Izumchenko E, Klein-Szanto AJ, Egleston BL, Wolfson M, et al. (2010) Enhanced genetic instability and dasatinib sensitivity in mammary tumor cells lacking NEDD9. Cancer Res 70: 8907-8916.
24. Huber MA, Kraut N, Beug H, (2005) Molecular requirements for epithelial-mesenchymal transition during tumor progression. Curr Opin Cell Biol 17: 548-558.
25. Le TL, Yap AS, Stow JL, (1999) Recycling of E-cadherin: a potential mechanism for regulating cadherin dynamics. J Cell Biol 146: 219-232.
26. Peifer M, Yap AS, (2003) Traffic control: p120-catenin acts as a gatekeeper to control the fate of classical cadherins in mammalian cells. J Cell Biol 163: 437-440.
27. Guo C, Liu QG, Yang W, Zhang ZL, Yao YM, (2008) Relation among p130Cas, E-cadherin and beta-catenin expression, clinicopathologic significance and prognosis in human hepatocellular carcinoma. Hepatobiliary Pancreat Dis Int 7: 490-496.
28. Bui LC, Tomkiewicz C, Chevallier A, Pierre S, Bats AS, et al. (2009) Nedd9/Hef1/Cas-L mediates the effects of environmental pollutants on cell migration and plasticity. Oncogene 28: 3642-3651.
29. Xing L, Ge C, Zeltser R, Maskevitch G, Mayer BJ, et al. (2000) c-Src signaling induced by the adapters Sin and Cas is mediated by Rap1 GTPase. Mol Cell Biol 20: 7363-7377.
30. Cabodi S, Tinnirello A, Bisaro B, Tornillo G, del Pilar Camacho-Leal M, et al. (2010) p130Cas is an essential transducer element in ErbB2 transformation. Faseb J 24: 3796-3808.
31. Tornillo G, Bisaro B, Camacho-Leal MD, Galie M, Provero P, et al. (2010) p130Cas promotes invasiveness of three-dimensional ErbB2-transformed mammary acinar structures by enhanced activation of mTOR/p70S6K and Rac1. Eur J Cell Biol.
32. Dadke D, Jarnik M, Pugacheva EN, Singh MK, Golemis EA, (2006) Deregulation of HEF1 impairs M-phase progression by disrupting the RhoA activation cycle. Mol Biol Cell 17: 1204-1217.
33. Giehl K, Menke A, (2008) Microenvironmental regulation of E-cadherin-mediated adherens junctions. Front Biosci 13: 3975-3985.
34. Tikhmyanova N, Tulin AV, Roegiers F, Golemis EA, (2010) Dcas supports cell polarization and cell-cell adhesion complexes in development. PLoS ONE 5.
35. Janda E, Nevolo M, Lehmann K, Downward J, Beug H, et al. (2006) Raf plus TGFbeta-dependent EMT is initiated by endocytosis and lysosomal degradation of E-cadherin. Oncogene.
36. Matsuyoshi N, Hamaguchi M, Taniguchi S, Nagafuchi A, Tsukita S, et al. (1992) Cadherin-mediated cell-cell adhesion is perturbed by v-src tyrosine phosphorylation in metastatic fibroblasts. J Cell Biol 118: 703-714.
37. Fujita Y, Krause G, Scheffner M, Zechner D, Leddy HE, et al. (2002) Hakai, a c-Cbl-like protein, ubiquitinates and induces endocytosis of the E-cadherin complex. Nat Cell Biol 4: 222-231.
38. Palacios F, Tushir JS, Fujita Y, D'Souza-Schorey C, (2005) Lysosomal targeting of E-cadherin: a unique mechanism for the down-regulation of cell-cell adhesion during epithelial to mesenchymal transitions. Mol Cell Biol 25: 389-402.
39. Braga VM, Machesky LM, Hall A, Hotchin NA, (1997) The small GTPases Rho and Rac are required for the establishment of cadherin-dependent cell-cell contacts. J Cell Biol 137: 1421-1431.
40. Shewan AM, Maddugoda M, Kraemer A, Stehbens SJ, Verma S, et al. (2005) Myosin 2 is a key Rho kinase target necessary for the local concentration of E-cadherin at cell-cell contacts. Mol Biol Cell 16: 4531-4542.
41. Sanz-Moreno V, Gadea G, Ahn J, Paterson H, Marra P, et al. (2008) Rac activation and inactivation control plasticity of tumor cell movement. Cell 135: 510-523.
42. Birukova AA, Malyukova I, Poroyko V, Birukov KG, (2007) Paxillin-beta-catenin interactions are involved in Rac/Cdc42-mediated endothelial barrier-protective response to oxidized phospholipids. Am J Physiol Lung Cell Mol Physiol 293: L199-211.
43. Briknarova K, Nasertorabi F, Havert ML, Eggleston E, Hoyt DW, et al. (2005) The serine-rich domain from Crk-associated substrate (p130Cas) is a four-helix bundle. J Biol Chem.
44. Ando Y, Yasuda S, Oceguera-Yanez F, Narumiya S, (2007) Inactivation of Rho GTPases with Clostridium difficile toxin B impairs centrosomal activation of Aurora-A in G2/M transition of HeLa cells. Mol Biol Cell 18: 3752-3763.
45. Enan E, Matsumura F, (1996) Identification of c-Src as the integral component of the cytosolic Ah receptor complex, transducing the signal of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) through the protein phosphorylation pathway. Biochem Pharmacol 52: 1599-1612.